Mass General Hospital

Harvard Medical School

Archive | Psychiatric Disorders During Pregnancy

In Brief: Do You Need to Take Vitamin or Mineral Supplements?

According to a recent national survey, 52% of adults in the United States reported using at least one dietary supplement.  Among the most popular are vitamin and mineral supplements, which are taken by 48% and 39% of adults, respectively.  It will undoubtedly surprise many that, despite the prevalent use of these supplements, most people do […]

Continue Reading · 0

Sacramento: What Can We Learn from a New Mother’s Experience of Postpartum Care?

Over the last few weeks, there has been a lot of coverage of a story involving a new mother from Sacramento.  You can read the details of the story here and here.  Basically, a new mother, Jessica, came to see her obstetrician with her 4-month old baby, explaining, “That I have postpartum depression that is […]

Continue Reading · 1

It’s OK to Throw Away Some of Those Baby Advice Books

When I meet with mothers of new babies, I often spend a fair amount of time delving into their beliefs about parenting and what they perceive as the “right” way to care for their new baby.  Granted, most of the new mothers I see suffer from depression or anxiety, but I can also look to […]

Continue Reading · 0

ADHD Medications in Pregnancy and Neonatal Outcomes

Analyzing data from the Swedish Medical Birth Register, the Prescribed Drug Register, and the Swedish Neonatal Quality Register, researchers compared infants exposed to ADHD medication during pregnancy with infants whose mothers never used these drugs and infants whose mothers used ADHD medication before or after (but not during) pregnancy.  Out of 964,734 infants included in […]

Continue Reading · 0

Good News: More Data on the Use of ADHD Medications During Pregnancy

For women with mild to moderate attention-deficit/hyperactivity disorder (ADHD) symptoms, we often recommend discontinuing stimulant medications and switching to a non-pharmacologic intervention.  Many women experience some decrease in their level of functioning; however, they are able to forgo or minimize pharmacologic treatment during pregnancy.  There are, however, women who experience more severe symptoms which interfere […]

Continue Reading · 0

Managing Opioid Dependence in Pregnancy: Outcomes in Children Exposed to Buprenorphine, Naltrexone, or Methadone

The use of opioid drugs in women of childbearing age has become a pressing public health concern.  It is clear that opiate use during pregnancy puts the mother and child at risk; opiate use during pregnancy has been associated with increased risk for oral clefts, neural tube defects, congenital heart defects, and ophthalmic problems.  In […]

Continue Reading · 0

Autism Spectrum Disorders and Maternal Nutrition

Current research suggests that autism spectrum disorders (ASD) occur as a result of events that take place during pregnancy.  While genetic factors play an important role, non-heritable risk factors contribute to a substantial proportion of ASD cases.  Maternal nutrition has been a focus of interest as a factor which may influence risk for ASD. However, […]

Continue Reading · 0

New Research from the CWMH: Risk of Gestational Diabetes in Women Taking Second Generation Antipsychotics During Pregnancy

The use of the newer “atypical” or second-generation antipsychotic (SGA) agents continues to increase.  These medications are used to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and anxiety disorders.  Although most of the women taking atypical antipsychotics are of childbearing age, our information on the reproductive safety of these […]

Continue Reading · 0

Examining the Association Between Anxiety Disorders and their Treatment in Pregnancy Outcomes

While numerous published studies have investigated the impact of treatments for major depressive disorder (MDD) in pregnancy on maternal and neonatal outcomes, few studies have examined the perinatal effects of anxiety disorders such as generalized anxiety disorder (GAD) and panic disorder (PD). Despite the comorbidity of the two types of psychiatric disorders in women of […]

Continue Reading · 0

Maternal Bipolar Disorder Not a Predictor of Infant Developmental Deficits at One Year of Age

  While some women with bipolar disorder elect to discontinue their psychotropic medications during pregnancy to mitigate fetal exposure, Viguera and colleagues (2000, 2007) found that women stabilized on lithium face a significant risk for relapse if they choose to discontinue treatment during pregnancy.  These treatment decisions are difficult and vary on a case-to-case basis, […]

Continue Reading · 2